APA (7th ed.) Citation

Combe, B. G., Tanaka, Y., Buch, M. H., Nash, P., Burmester, G. R., Kivitz, A. J., . . . Aletaha, D. (2023). Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study. Rheumatology & Therapy, 10(1), 53. https://doi.org/10.1007/s40744-022-00498-x

Chicago Style (17th ed.) Citation

Combe, Bernard G., et al. "Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study." Rheumatology & Therapy 10, no. 1 (2023): 53. https://doi.org/10.1007/s40744-022-00498-x.

MLA (9th ed.) Citation

Combe, Bernard G., et al. "Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study." Rheumatology & Therapy, vol. 10, no. 1, 2023, p. 53, https://doi.org/10.1007/s40744-022-00498-x.